A collaborative study with Harvard Medical School
Management of Malignant Fungating Wounds with a Bioactive Microfibre Gelling Technology Dressing: An Evaluation
Publication Details:
Pramod, S., 2023. Management of malignant fungating wounds with a bioactive microfibre gelling technology dressing: an evaluation.
Wound Details
Malignant fungating wounds are non-healing wounds resulting from aggressive cancerous cell proliferation.
Key Findings and Data:
- 66.7% reduction in pain, with the average pain score decreasing from 6 to 2 on the Visual Analogue Scale (VAS)
- Maceration and excoriation reducing from 70% to 0%
- Average wound area reduced by 13.7%, from 51 cm² to 44 cm²
- Slough and necrotic tissue decreased from 65.5% to 25.5%
Key Insights
- The positively charged MaxioCel® fibers exhibited haemostatic, antimicrobial, antibiofilm, and exudate-management properties, enhancing wound healing while reducing inflammation and pain.
- The study emphasizes the need for interdisciplinary collaboration in managing oncology wounds, highlighting education gaps in healthcare settings.
Related Publications
Use of Chitosan-based Dressings for the Management of a Chronic Lower Limb Ulcer
Evaluation of a bioactive microfibre
gelling dressing
MaxioCel in the management of malignant
fungating wounds
Evaluation of a Chitosan Dressing in the Management of Hard-to-Heal Wounds
